Varma Mutual Pension Insurance Company

IQM Quantum Computers, founded in 2018 and headquartered in Espoo, Finland, specializes in developing and manufacturing hardware systems for quantum computing. The company focuses on scalable hardware solutions utilizing superconducting technology to build quantum processors for universal quantum computers. By concentrating on practical applications, IQM aims to enhance quantum computing capabilities and address challenges faced by various industries and society. As a spin-out from Aalto University and the VTT Technical Research Centre of Finland, IQM has achieved significant advancements in areas such as thermal management, which are crucial for improving computational speed and information accuracy. The company's innovations position it as a leader in the global pursuit of large-scale quantum computing solutions. IQM also offers access to its hardware for research laboratories and supercomputing centers, helping businesses reduce error rates that currently limit computing performance.

Mediverkko is a Finland-based healthcare and social service provider that caters to both private and municipal customers. Established in 2002, the company offers a comprehensive range of services, including healthcare, dental clinics, elderly care, and child welfare services, primarily for public sector partners. Mediverkko focuses on delivering cost-effective health and care solutions. In 2014, the company was acquired by Mehiläinen, further enhancing its capacity to serve its clients effectively.

Vivoxid Ltd. develops, manufactures, and markets biomaterial products for the medical device sector. The company offers MetAlive soft tissue attachment technology for implant surfaces. BonAlive bioactive glass and biodegradable polymer composite products in bone reconstruction and FiberLive biodegradable fiberglass composites for load-bearing biodegradable implants. It has distributors in northern Europe, the United Kingdom, southern Europe, Italy, Greece, Turkey, the Middle East, and Saudi Arabia. The company was founded in 2001 and is based in Turku, Finland.

Ipsat Therapies, a biotechnology company, develops intestinal protection systems in antibiotic treatment. It focuses on the development of products for the prevention of antibiotic resistance, antibiotic-associated diarrhea, and hospital associated infections. The company offers bioengineered enzyme, which removes the excess unabsorbed harmful antibiotic in intestine and maintains a normal intestinal microflora. It also develops various antibiotics, including penicillin, cephalosporin, carbapenems, and fixed combination products. Ipsat Therapies Oy was founded in 1999 and is based in Helsinki, Finland.